Thursday
Jul232009
Great Plains GOP Senators Say No To Cap And Trade
By Learned Foote- Talk Radio News Service
Three GOP senators from Great Plains states criticized the cap-and-trade bill that recently passed in the House of Representatives, and is currently being reviewed in the Senate.
According to Sen. Pat Roberts (R-Ky.), the bill is a "wet dog that is not welcome in the farmhouse or the ranch." Sen. Mike Johanns (R-Neb.) firmly said that "this bill is not going to work in the Senate," and claimed that it lacks "even a 5% chance of being successful."
Sen. Johanns, formerly the Secretary of Agriculture under President George W. Bush, said that the legislation would hurt the economy, especially in agricultural communities. "The average farmer will never buy into the idea that maybe, just maybe, if they pay higher production costs and go through this regimen that is going to be established, that they might do better," he said.
The Senators dismissed testimony given by the United States Department of Agriculture to the Agriculture Committee on Wednesday. "The USDA analysis...has holes enough to drive a grain truck through," said Sen. Roberts. He said it was based on assumptions of the EPA [Environmental Protection Agency], which he argued is "driven by their agenda. I don't think it is driven by accurate assessment...as to the effect on farmers and ranchers in rural, small-town America."
Sen. Johanns said he has worked with the economists of the USDA in the past, and that they produce "excellent work." He maintained, however, that this analysis is "tragically incomplete" and it is "remarkable how deficient it is in analysis."
Sen. John Thune (R-S.D.) questioned how effectively the legislation could protect the environment, arguing that other carbons will not act to cut carbon emissions, thus stripping the U.S. of competitive advantage in the marketplace. He said that the "costs are real and the savings are theoretical."
The GOP Senators suggested that another piece of legislation could gain bipartisan support. "We ought to be serious abut reducing CO2 emissions," said Thune. He emphasized "incentives for rural renewable energy production," which he said would avoid a "crushing economic burden on American business."
Three GOP senators from Great Plains states criticized the cap-and-trade bill that recently passed in the House of Representatives, and is currently being reviewed in the Senate.
According to Sen. Pat Roberts (R-Ky.), the bill is a "wet dog that is not welcome in the farmhouse or the ranch." Sen. Mike Johanns (R-Neb.) firmly said that "this bill is not going to work in the Senate," and claimed that it lacks "even a 5% chance of being successful."
Sen. Johanns, formerly the Secretary of Agriculture under President George W. Bush, said that the legislation would hurt the economy, especially in agricultural communities. "The average farmer will never buy into the idea that maybe, just maybe, if they pay higher production costs and go through this regimen that is going to be established, that they might do better," he said.
The Senators dismissed testimony given by the United States Department of Agriculture to the Agriculture Committee on Wednesday. "The USDA analysis...has holes enough to drive a grain truck through," said Sen. Roberts. He said it was based on assumptions of the EPA [Environmental Protection Agency], which he argued is "driven by their agenda. I don't think it is driven by accurate assessment...as to the effect on farmers and ranchers in rural, small-town America."
Sen. Johanns said he has worked with the economists of the USDA in the past, and that they produce "excellent work." He maintained, however, that this analysis is "tragically incomplete" and it is "remarkable how deficient it is in analysis."
Sen. John Thune (R-S.D.) questioned how effectively the legislation could protect the environment, arguing that other carbons will not act to cut carbon emissions, thus stripping the U.S. of competitive advantage in the marketplace. He said that the "costs are real and the savings are theoretical."
The GOP Senators suggested that another piece of legislation could gain bipartisan support. "We ought to be serious abut reducing CO2 emissions," said Thune. He emphasized "incentives for rural renewable energy production," which he said would avoid a "crushing economic burden on American business."
House Dems Seek “Fairer Pricing” For Prescription Drugs Within Health Reform
A group of Democratic Congressmen introduced proposals on Thursday known as the CARE (Cut Americans’ Rx Expenses) Package. This package would seek to reduce the costs of prescription drugs, and thereby create savings worth $190 billion dollars that could be applied to health care reform.
The package has three amendments which the Congressmen will seek to insert into the legislation. Rep. Jane Harman (D-Calif.) said that Chairman of the House Energy and Commerce Committee Henry Waxman (D-Calif.) agreed to support these proposals during mark-up.
Rep. Peter Welch (D-Vt.) said that pharmaceutical companies “create life-extending, pain-relieving, life-saving drugs,” but also “charge very high prices and have an excessive control over the marketplace.”
Rep. Harman said that the first proposal seeks to reverse a 2003 law that passed 220-215, which prohibits the Health and Human Services Secretary from bargaining for lower prices for pharmaceuticals for Medicare D patients. She said the law represents a “poignant example of Congress’ failure to take meaningful action to rein in drug costs.”
According to Rep. Castor, the bill's second amendment allows a potential public option to “negotiate prices” and to establish a formulary. A prepared press release said that such a formulary would mean that “families who choose the public option are guaranteed the lowest cost for prescriptions.”
Rep. Betty Sutton said that the final provision “will require...drug manufacturers to pay a supplemental rebate when name-brand drugs exceed the current rate of inflation.” She said the companies “won’t have to pay these rebates if they decide not to jack up their drug prices above the rate of inflation.” She added that this proposal will incentivize drug companies to “show reasonable restraint, thereby making prescription drug prices more affordable.”
Rep. Kathy Castor (D-Fl.) noted that Americans pay higher prices for drugs than do consumers in other countries. Rep. John Sarbanes (D-Md.) said that the government has “terrific bargaining power.” He wondered “why shouldn’t the government in dealing with the pharmaceutical industry be able to go into the marketplace and use that bargaining power on behalf of seniors, on behalf of working families across the country?”
The members of Congress proposing this legislation include Reps. Jane Harman (D-Calif.), Anthony Weiner (D-N.Y.), Kathy Castor (D-Fla.), John Sarbanes (D-Md.), Betty Sutton (D-Ohio), and Peter Welch (D-Vt.).